In this episode of Stem Cell Revolution, host Donna Chang engages in a fascinating discussion with Sherry Diers about the groundbreaking world of mesenchymal stem cells (MSCs). The conversation delves into the fundamental differences between MSCs and hematopoietic stem cells, explaining that while hematopoietic stem cells need to be matched to prevent rejection, MSCs are remarkably adaptable and can be sourced from any donor without the same risk of immune rejection.

Sherry and Donna explore how MSCs have shown significant promise in animal trials and numerous clinical studies, citing over 1200 trials with a large number achieving positive results. Despite this, MSCs are still awaiting broader approval in the U.S., leading to a deeper investigation into why many pivotal phase three trials have failed. They discuss the inherent challenges in scaling trials, variability in patient responses, and the difficulties in maintaining cell consistency across large trials.

The conversation also touches on the challenges associated with autologous MSCs, including donor-to-donor variability and the complexities of scaling up production. Sherry and Donna examine the issues surrounding allogeneic MSCs, such as the need for consistent donor cell quality and the difficulties in mass production and preservation.

The episode highlights the impressive safety record of MSCs and their potential in treating various conditions, including immune system disorders and cancer. Donna emphasizes that while MSCs have shown tremendous potential, the focus now is on resolving the technical challenges to fully harness their therapeutic capabilities. The discussion concludes with a hopeful outlook on the future of MSCs, emphasizing their role in treating, preventing, and potentially revolutionizing healthcare.

Tune in to Stem Cell Revolution for an insightful exploration of the cutting-edge field of stem cell therapy and the promising future of MSCs.


Links:

WEBSITE - https://www.hope.bio
INSTAGRAM -   / hope.bio  
TWITTER -   / hopebiosciences  
FACEBOOK -   / hopebiosciences